![]() |
![]() |
![]() |
Structure-function studies of ion channels. transgenic animal models of cardiovascular research. signal transduction in cancer biology curing cancer. sexually transmitted diseaseOur laboratory explores the molecular and cellular function of membrane proteins. specifically. we are interested in the structure-function relationship of ion channels. the molecular basis of genetic diseases caused by mutations in membrane proteins. and the application of our research to clinical and pharmaceutical discoveries. Currently. we have five projects on going in the laboratory: a) structure-function study of Ca channels and their role in excitation-contraction coupling of skeletal and cardiac muscles; b) transgenic animal models (gene knock out and knock in) to understand the function of muscle specific proteins in both physiological and pathophysiological conditions; c) function and regulation of the CFTR chloride channel and its implication in the therapeutic intervention of cystic fibrosis; d) Ca signaling and cytochrome c release in apoptosis; and e) high throughput screening assays of chemicals targeting at the insect isoform of ryanodine receptor. We do our researches through collaboration with colleagues both on- and off-campuses. We routinely employ the following experimental tools with a particular physiological question: a) molecular cloning and mutagenesis. and heterologous expression of eukaryotic genes; b) immunological and biochemical assays of recombinant proteins; c) confocal microscopic imaging of intracellular ion movement and subcellular localization of GFP-tagged molecules; d) morphological and biological assays of cells undergoing apoptosis or treated with different stimuli; e) NMR structural determination of synthetic peptides or recombinant proteins; and f) electrophysiological characterization of single ion channel activities using lipid bilayer reconstitution and patch clamp measurement. Our researches are supported by grants from the National Institutes of Health (RO1-DK51770. RO1-AG15556. and RO1-CA97357). and Cystic Fibrosis Foundation. and FMC Corporation. View Dr. Ma's publications in Pub Med |